The approval of Retevmo is for the treatment of adults and children aged 2 years and older with advanced or metastatic medullary thyroid cancer. The Food and Drug Administration (FDA) approved Retevmo ...

In an interview with Medscape, Manisha H. Shah, MD, a medical oncologist in the Department of Internal Medicine at the Ohio State University Comprehensive Cancer Center, discussed the genetic risk ...

Retevmo as a treatment for patients with advanced RET-mutant medullary thyroid cancer “is very exciting,” as treatment options were previously limited, an expert told CURE®. Treatment with Retevmo ...

MTC patients who were initiated on RETi between 2018 and 2022 were included. Baseline characteristics, RET mutational status, RETi response, available tumor tissue and molecular profiles sampled pre- ...

MONDAY, Nov. 17, 2025 (HealthDay News) — Thyroid cancer is often a highly treatable disease. Most cases are detected in early stages and have excellent outcomes. There are several different types of ...

What Is Medullary Carcinoma Thyroid (MTC)? Medullary carcinoma is a rare type of cancer that can appear in different parts of the body. It most commonly shows up in the thyroid gland and the colon.

Receiving a diagnosis of thyroid cancer can be upsetting and confusing, especially if a doctor suggests that a patient wait to see how the cancer progresses before pursuing any specific treatment.

Are Needs Assessments Cost Effective in Reducing Distress Among Patients With Cancer? A Randomized Controlled Trial Using the Distress Thermometer and Problem List We conducted a double-blind, phase ...

The FDA approved selpercatinib for treatment of metastatic medullary thyroid cancer in patients 2 years and older with a RET mutation. Selpercatinib previously received accelerated approval for ...

A newly developed PET imaging agent has been found to be effective in identifying medullary thyroid cancer (MTC) in preclinical and clinical studies, according to research published in the January ...

BOSTON RED SOX PLAYER. MIKE GREENWELL, NOW 62 YEARS OLD AND LIVING IN FLORIDA, SAYS HE’S BEEN DIAGNOSED WITH MEDULLARY THYROID CANCER. GREENWELL BECAME A FAN FAVORITE IN 1988 AFTER REPLACING HALL OF ...